03.07.2009 3 июля 2009, 00:00 3136 просмотров

Pharmacy Chain 36.6 reports 10.9% revenue drop

Russian Pharmacy Chain 36.6 reported that its retail EBITDA improved by more than RUB300 million (USD8.61 million) in Q1 2009. Group revenue from ongoing operations decreased 10.9% to RUB5.86 billion (USD168.17 million). The retail unit opened seven and closed 50 stores in Q1 2009. Commenting on Q1 2009 results, Jere Calmes, President and CEO, said: “Our Q1 2009 results underscore the operational improvements made across the group’s pharmaceutical retail chain, especially in the Moscow-Central Business Unit and the solid performance of our manufacturing unit, Veropharm. Nevertheless, our current operating environment remains severely strained and we continue to work with our Board of Directors to raise the required funding to complete our turnaround.” Q1 2009 sales in its retail unit decreased 14.2% to RUB4.79 billion (USD137.46 million), driven by the closure of non-performing stores and a drop in like-for-like sales. Like-for-like sales in Q1 decreased 8% in rouble terms (35% in dollar terms), driven by out-of-stocks and a decline in customer traffic.

www.planetretail.net

Статья относится к тематикам: Актуально
Поделиться публикацией:
От особенностей поведения до особенностей потребле...
815
Илья Блинов, генеральный директор компании «Милфор...
726
Виктория Харламова, руководитель направления китай...
667
Артем Тараев, генеральный директор «К-раута»
1720
Применение 54-ФЗ на примере сети из 48 магазинов
558
Количество наименований в чеке увеличилось на 20%,...
589

Russian Pharmacy Chain 36.6 reported that its retail EBITDA improved by more than RUB300 million (USD8.61 million) in Q1 2009. Group revenue from ongoing operations decreased 10.9% to RUB5.86 billion (USD168.17 million). The retail unit opened seven and closed 50 stores in Q1 2009. Commenting on Q1 2009 results, Jere Calmes, President and CEO, said: “Our Q1 2009 results underscore the operational improvements made across the group’s pharmaceutical retail chain, especially in the Moscow-Central Business Unit and the solid performance of our manufacturing unit, Veropharm. Nevertheless, our current operating environment remains severely strained and we continue to work with our Board of Directors to raise the required funding to complete our turnaround.” Q1 2009 sales in its retail unit decreased 14.2% to RUB4.79 billion (USD137.46 million), driven by the closure of non-performing stores and a drop in like-for-like sales. Like-for-like sales in Q1 decreased 8% in rouble terms (35% in dollar terms), driven by out-of-stocks and a decline in customer traffic.

www.planetretail.net

Pharmacy Chain 36.6 reports 10.9% revenue dropPharmacy Chain, 36.6
http://www.retail.ru/local/templates/retail/images/logo/login-retail-big.png 243 67
Pharmacy Chain 36.6 reports 10.9% revenue drop
http://www.retail.ru/local/templates/retail/images/logo/login-retail-big.png 243 67
SITE_NAME http://www.retail.ru
http://www.retail.ru/news/38608/2017-05-25